Carmel Wroth
Carmel Wroth is a senior health editor for NPR's Science Desk, where she guides digital strategy for the health team and conceives and edits digital-first, enterprise stories and packages.
Formerly, she founded and managed Side Effects Public Media, a public radio collaborative covering public health in the Midwest. Wroth also served as an editor at Yoga Journal for five years.
-
A new survey finds more people are surviving lung cancer and racial disparities are shrinking. But unless it's caught early, lung cancer still has a low survival rate. -
After years of high rates, the country hit a new high during the pandemic, far exceeding rates in other developed nations. Black women are at especially high risk. -
After years of high rates, the country hit a new high during the pandemic, far exceeding rates in other developed nations. Black women are at especially high risk.
-
You might want to cancel that holiday party, and definitely dust off your face mask. Don't panic, but do step up your precautions. Here's how. -
Roughly 175,000 children in the U.S. have lost one or both parents or a grandparent caregiver to COVID-19, according to a new study. The majority come from racial and ethnic minority groups. -
Though infections are still sky-high, the U.S. may be turning a corner, according to a consortium of researchers who forecast the pandemic. And we may well be spared a winter surge. -
If all goes to plan, Americans who got Pfizer or Moderna shots can get a third dose eight months after their last jab. Here's why health officials think you'll need one. -
People with weakened immune systems who already got two doses of the Pfizer or Moderna COVID-19 vaccines can now get a third shot. But exactly who is eligible? Here's what we know so far. -
The highly contagious delta variant of the coronavirus is spreading fast and driving new cases and hospitalizations. Here's what you need to know to keep yourself and your kids from getting sick. -
As the delta variant takes over in the U.S., new, localized outbreaks are emerging. Those surges are likely driven by pockets of dangerously low vaccination rates.
